clinical trial · NCT07116551
Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis
Abbott Medical Devices·N/A·active not recruiting·n = 11
Symptomatic Severe Aortic StenosisAbbott BE TAVI System
brief summary
The purpose of this study is to evaluate the safety and functionality of Abbott's BE TAVI system for the treatment of patients with symptomatic severe aortic valve stenosis.
started
Oct 30, 2025
primary completion
Jun 1, 2031
completion
Jun 1, 2031
last updated
Feb 6, 2026
detailed description
The EFS will evaluate the safety and functionality of Abbott's BE TAVI system for the treatment of patients with symptomatic severe aortic valve stenosis.
official title
Abbott BE TAVI Early Feasibility Study: Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol